These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2151298)

  • 1. HPLC and flow cytometric analyses of uptake of adriamycin and menogaril by monolayers and multicell spheroids.
    Bichay TJ; Adams EG; Inch WR; Adams WJ; Brewer JE; Bhuyan BK
    Sel Cancer Ther; 1990; 6(4):153-66. PubMed ID: 2151298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro.
    Durand RE
    Cancer Res; 1981 Sep; 41(9 Pt 1):3495-8. PubMed ID: 7260912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.
    Badiner GJ; Moy BC; Smith KS; Tarpley WG; Groppi VE; Bhuyan BK
    Br J Cancer; 1990 Sep; 62(3):378-84. PubMed ID: 2145026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of V79 multicell spheroids to mitoxantrone: drug uptake and cytotoxicity.
    Bichay TJ; Inch WR
    Cancer Drug Deliv; 1987; 4(4):201-11. PubMed ID: 3454247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of oxygen free radical formation in the mechanism of menogaril resistance in multidrug resistant tumor cells.
    Sinha BK; Atwell J; Politi PM
    Chem Biol Interact; 1990; 76(1):89-99. PubMed ID: 2168296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents.
    Bhuyan BK; Zimmer DM; Mazurek JH; Trzos RJ; Harbach PR; Shu VS; Johnson MA
    Cancer Res; 1983 Nov; 43(11):5293-7. PubMed ID: 6225515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.
    Wierzba K; Sugimoto Y; Matsuo K; Toko T; Takeda S; Yamada Y; Tsukagoshi S
    Jpn J Cancer Res; 1990 Aug; 81(8):842-9. PubMed ID: 2144516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of genes differentially expressed in V79 cells grown as multicell spheroids.
    Oloumi A; Lam W; Banáth JP; Olive PL
    Int J Radiat Biol; 2002 Jun; 78(6):483-92. PubMed ID: 12065053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic studies of menogaril (TUT-7) with rats].
    Ohashi K; Hara H; Takahashi F; Aso R; Akimoto T; Nakama K
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1825-9. PubMed ID: 1387773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival.
    Bhuyan BK; McGovren JP; Crampton SL
    Cancer Res; 1981 Mar; 41(3):882-7. PubMed ID: 6450639
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
    Erlichman C; Vidgen D
    Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: influence of growth kinetics, growth environment and DNA packaging.
    Olive PL; Banáth JP; Evans HH
    Br J Cancer; 1993 Mar; 67(3):522-30. PubMed ID: 8382510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?
    Durand RE
    Cancer Chemother Pharmacol; 1990; 26(3):198-204. PubMed ID: 2357767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser flow cytometric studies on the intracellular fluorescence of anthracyclines.
    Krishan A; Ganapathi R
    Cancer Res; 1980 Nov; 40(11):3895-900. PubMed ID: 6937236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids.
    Rodriguez A; Alpen EL; Mendonca M; DeGuzman RJ
    Radiat Res; 1988 Jun; 114(3):515-27. PubMed ID: 3375440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.
    Egorin MJ; Conley BA; Forrest A; Zuhowski EG; Sinibaldi V; Van Echo DA
    Cancer Res; 1987 Nov; 47(22):6104-10. PubMed ID: 2959359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
    Chandrasekaran B; Dimling J; Capizzi RL
    Cancer Treat Rep; 1987 Feb; 71(2):195-6. PubMed ID: 2948640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ultrasound on the cytotoxicity of adriamycin.
    Loverock P; ter Haar G; Ormerod MG; Imrie PR
    Br J Radiol; 1990 Jul; 63(751):542-6. PubMed ID: 2390688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitivity testing in V79 spheroids: drug delivery and cellular microenvironment.
    Durand RE
    J Natl Cancer Inst; 1986 Jul; 77(1):247-52. PubMed ID: 2425117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.